Precision Business Insights
Portfolio

 

Spinal Muscular Atrophy (SMA) Treatment Market

: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Spinal Muscular Atrophy (SMA) Treatment Market: By Treatment (Gene Therapy, ), Route of Administration (Oral, Intrathecal), Disease Type (Type 1, Type 2, Type 3, Type 4) and Geography

 

Global Spinal Muscular Atrophy (SMA) Treatment Market Report Description:

Global spinal muscular atrophy (SMA) treatment market report gives comprehensive outlook on spinal muscular atrophy (SMA) treatment technology across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global spinal muscular atrophy (SMA) treatment market gives historical, current, and future market sizes (US$ Mn) on the basis of treatment, route of administration, disease type and region. This report studies global spinal muscular atrophy (SMA) treatment market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global spinal muscular atrophy (SMA) treatment market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global spinal muscular atrophy (SMA) treatment market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global spinal muscular atrophy (SMA) treatment market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global spinal muscular atrophy (SMA) treatment products.

 

Global Spinal Muscular Atrophy (SMA) Treatment Market:

The global spinal muscular atrophy (SMA) treatment market estimated to be valued US$ XX Mn in 2018 and elegant to grow at significant CAGR over 2019-2025 due to increase in awareness regarding the disease (SMA), increase in the research for the rare disease treatment, initiative by government and private organizations to create awareness about the disease SMA, increase in number of initiatives for the treatment procedures of rare diseases, innovation of drugs and other therapies for the treatment and complex nature of the disease are the major factors that are driving the growth of the global spinal muscular atrophy (SMA) treatment market over the forecast timeframe.

 

Increase in the Approval of Orphan Drugs

Increase in the approval of orphan drugs especially in spinal muscular atrophy (SMA) and growing number of R&D activities for the orphan drugs are the factors that drive the growth of market. For instance, in 2017, USFDA granted an orphan drug license for the treatment of spinal muscular atrophy that is RG7916 which is a development programme by Roche, SMA foundation, and PTC therapeutics.  These approvals are expected to increase the research in the field of orphan drugs and are anticipated to propel the global spinal muscular atrophy (SMA) treatment market over the forecast years.

 

North America Accounts for Larger Market Revenue Share in Global Spinal Muscular Atrophy (SMA) Treatment Market

North America accounted for larger revenue share in global spinal muscular atrophy (SMA) treatment market with significant CAGR and expected to dominate further. Enhanced R&D activities, approved drug for the treatment of SMA (Spinraza), presence of major market player Biogen Inc. in US, high disposable income, and rise in the adaptation of spinraza are anticipated to drive the market. Asia pacific spinal muscular atrophy (SMA) treatment market projected to grow at significant rate owing to increase in research and development, rapidly developing health infrastructure in countries such as China and India, increasing number of initiatives to improve the access tSMA therapies are expected to enhance the market.

 

Competition Assessment

Key player’s profiles in the global spinal muscular atrophy (SMA) treatment market include:

  • Biogen
  • Ionis Pharmaceuticals, Inc.
  • Hoffmann – La Roche Ltd
  • Avexis, Inc.
  • Novartis AG
  • Cytokinetics, Inc.
  • Voyager Therapeutics

Key Findings of the Report:

 

  • Global spinal muscular atrophy (SMA) treatment market expanding at significant CAGR over 2019 to 2025 owing to increase in the prevalence of cancer, diabetes, and other infectious diseases.
  • Based on type of route of administration, intrathecal route accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer technologies and collaboration strategies to retain market position in global spinal muscular atrophy (SMA) treatment market.

Detailed Segmentation

 

By Treatment

 

  • Gene Therapy
  • Drug

By Route of administration

 

  • Oral
  • Intrathecal

 By Disease type

 

  • Type 1
  • Type 2
  • Type 3
  • Type 4

 

Geography

 

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA
  1. Executive Summary
  2. Global Spinal Muscular Atrophy (SMA) Treatment Market Introduction
    • Global Spinal Muscular Atrophy (SMA) Treatment Market – Taxonomy
    • Global Spinal Muscular Atrophy (SMA) Treatment Market –Definitions
      • By Treatment
      • By Route of Administration
      • By Disease Type
      • By Region
  1. Global Spinal Muscular Atrophy (SMA) Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Spinal Muscular Atrophy (SMA) Treatment Market Dynamic Factors – Impact Analysis
    • Global Spinal Muscular Atrophy (SMA) Treatment Market – Competition Landscape
  2. Global Spinal Muscular Atrophy (SMA) Treatment Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Spinal Muscular Atrophy (SMA) Treatment Market, By Treatment, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Gene Therapy
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Drug Therapy
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast, By Route Of Administration, 2014 – 2018 and Forecast, 2019 – 2025
    • Oral
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Intrethecal
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast, By Disease Type, 2014 – 2018 and Forecast, 2019 – 2025
    • Type 1
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Type 2
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Type 3
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Type 4
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Spinal Muscular Atrophy (SMA) Treatment Market – Opportunity Analysis Index, By Treatment, Route of Administration, Disease Type, and Region, 2019 – 2025
  2. North America Spinal Muscular Atrophy (SMA) Treatment Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Treatment, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gene Therapy
      • Drug
    • By Route of Administration Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intrathecal
    • By Disease Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Type 1
      • Type 2
      • Type 3
      • Type 4
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Spinal Muscular Atrophy (SMA) Treatment Market – Opportunity Analysis Index, By Treatment, Route of Administration, Disease Type, and Country, 2019 – 2025
    • North America Spinal Muscular Atrophy (SMA) Treatment Market Dynamics – Trends
  3. Europe Spinal Muscular Atrophy (SMA) Treatment Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Treatment, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gene Therapy
      • Drug
    • By Route of Administration Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intrathecal
    • By Disease Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Type 1
      • Type 2
      • Type 3
      • Type 4
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Spinal Muscular Atrophy (SMA) Treatment Market – Opportunity Analysis Index, By Treatment, Route of Administration, Disease Type, and Country, 2019 – 2025
    • Europe Spinal Muscular Atrophy (SMA) Treatment Market Dynamics – Trends
  4. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Treatment, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gene Therapy
      • Drug
    • By Route of Administration Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intrathecal
    • By Disease Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Type 1
      • Type 2
      • Type 3
      • Type 4
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market – Opportunity Analysis Index, By Treatment, Route of Administration, Disease Type, and Country, 2019 – 2025
    • Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Dynamics – Trends
  5. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Treatment, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gene Therapy
      • Drug
    • By Route of Administration Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intrathecal
    • By Disease Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Type 1
      • Type 2
      • Type 3
      • Type 4
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Spinal Muscular Atrophy (SMA) Treatment Market – Opportunity Analysis Index, By Treatment, Route of Administration, Disease Type, and Country, 2019 – 2025
    • Latin America Spinal Muscular Atrophy (SMA) Treatment Market Dynamics – Trends
  6. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Treatment, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gene Therapy
      • Drug
    • By Route of Administration Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intrathecal
    • By Disease Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Type 1
      • Type 2
      • Type 3
      • Type 4
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Spinal Muscular Atrophy (SMA) Treatment Market – Opportunity Analysis Index, By Treatment, Route of Administration, Disease Type, and Country, 2019 – 2025
    • MEA Spinal Muscular Atrophy (SMA) Treatment Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Route of Administration & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Biogen
      • Ionis Pharmaceuticals, Inc.
      • Hoffmann – La Roche Ltd
      • Avexis, Inc.
      • Novartis AG
      • Cytokinetics, Inc.
      • Voyager Therapeutics
  1. Research Methodology
  2. Key Assumptions and Acronyms
$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials